These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30788385)
41. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle. Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924 [TBL] [Abstract][Full Text] [Related]
42. Phenotypic Characterization of Male Tomczewski MV; Chan JZ; Campbell ZE; Strathdee D; Duncan RE Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831174 [TBL] [Abstract][Full Text] [Related]
43. Defining functional classes of Barth syndrome mutation in humans. Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608 [TBL] [Abstract][Full Text] [Related]
44. Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth syndrome. Malhotra A; Kahlon P; Donoho T; Doyle IC Recent Pat Biotechnol; 2014; 8(2):136-43. PubMed ID: 25185984 [TBL] [Abstract][Full Text] [Related]
45. Barth syndrome mutations that cause tafazzin complex lability. Claypool SM; Whited K; Srijumnong S; Han X; Koehler CM J Cell Biol; 2011 Feb; 192(3):447-62. PubMed ID: 21300850 [TBL] [Abstract][Full Text] [Related]
46. N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics. Chan JZ; Fernandes MF; Steckel KE; Bradley RM; Hashemi A; Groh MR; Sciaini G; Stark KD; Duncan RE Sci Rep; 2022 Jun; 12(1):9466. PubMed ID: 35676289 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1. Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168 [TBL] [Abstract][Full Text] [Related]
52. Case Report: A Chinese child with Barth syndrome caused by a novel Che M; Li F; Jia Y; Liu Q; Hu J; Zhang J; Liu S Front Cardiovasc Med; 2024; 11():1465912. PubMed ID: 39309604 [TBL] [Abstract][Full Text] [Related]
53. Prenatal case report of Barth syndrome caused by novel Zhao X; Li X; Sun W; Jia JA; Yu M; Tian R Front Pediatr; 2022; 10():1004485. PubMed ID: 36440345 [TBL] [Abstract][Full Text] [Related]
54. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome. Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro Brás LE; Funai K J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435 [TBL] [Abstract][Full Text] [Related]
55. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Wang G; McCain ML; Yang L; He A; Pasqualini FS; Agarwal A; Yuan H; Jiang D; Zhang D; Zangi L; Geva J; Roberts AE; Ma Q; Ding J; Chen J; Wang DZ; Li K; Wang J; Wanders RJ; Kulik W; Vaz FM; Laflamme MA; Murry CE; Chien KR; Kelley RI; Church GM; Parker KK; Pu WT Nat Med; 2014 Jun; 20(6):616-23. PubMed ID: 24813252 [TBL] [Abstract][Full Text] [Related]
56. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription. Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223 [TBL] [Abstract][Full Text] [Related]
58. A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome. Zapała B; Płatek T; Wybrańska I Ann Hum Genet; 2015 May; 79(3):218-24. PubMed ID: 25776009 [TBL] [Abstract][Full Text] [Related]